Eversept Partners’s Intuitive Surgical ISRG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.88M Sell
7,241
-3,878
-35% -$1.69M 0.15% 80
2026
Q1
$5.13M Sell
11,119
-6,943
-38% -$3.51M 0.27% 59
2025
Q4
$10.2M Buy
18,062
+3,636
+25% +$1.94M 0.52% 52
2025
Q3
$6.45M Buy
+14,426
New +$6.92M 0.44% 47
2022
Q4
Sell
-9,125
Closed -$1.71M 72
2022
Q3
$1.71M Buy
9,125
+534
+6% +$115K 0.15% 51
2022
Q2
$1.72M Buy
8,591
+428
+5% +$100K 0.12% 57
2022
Q1
$2.46M Sell
8,163
-1,662
-17% -$486K 0.19% 60
2021
Q4
$3.53M Buy
9,825
+390
+4% +$134K 0.23% 69
2021
Q3
$3.13M Buy
9,435
+1,686
+22% +$566K 0.22% 62
2021
Q2
$2.38M Hold
7,749
0.16% 63
2021
Q1
$1.91M Buy
+7,749
New +$1.95M 0.1% 63

Other funds holding ISRG

Eversept Partners's ISRG Position: Q2 2026 in Review

Eversept Partners reduced its Intuitive Surgical (ISRG) stake by 35% in Q2 2026, selling an estimated $1.69M and leaving 7,241 shares worth $2.88M. The position accounts for 0.15% of the portfolio, ranked #80.

Eversept Partners first reported a position in ISRG in Q1 2021 and has held it in 11 quarters since. The position peaked at $10.2M in Q4 2025. 2,250 funds tracked by Wall St. Rank hold ISRG as of Q2 2026.

  • Eversept Partners held 7,241 shares of Intuitive Surgical worth $2.88M as of Q2 2026.
  • Eversept Partners sold 3,878 Intuitive Surgical shares in Q2 2026, an estimated $1.69M.
  • Intuitive Surgical made up 0.15% of Eversept Partners's portfolio in Q2 2026, its #80 holding.
  • Eversept Partners first reported a position in Intuitive Surgical in Q1 2021 and has held it in 11 quarters since.
  • Eversept Partners's Intuitive Surgical position peaked at $10.2M in Q4 2025.
  • 2,250 funds tracked by Wall St. Rank held Intuitive Surgical as of Q2 2026.

Based on Eversept Partners's 13F filing for Q2 2026, filed 14 Aug 2026.